skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,037  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: subject: Clinical Trials remove Journal Title: M2 Presswire remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Burns Pipeline and Clinical Trials Assessment, 2024 Updates: FDA Approvals, Therapies and Key Companies involved by DelveInsight | MediWound, Kaken Pharma, Kerecis, Medline, Mallinckrodt Pharma
Material Type:
Newspaper Article
Add to My Research

Burns Pipeline and Clinical Trials Assessment, 2024 Updates: FDA Approvals, Therapies and Key Companies involved by DelveInsight | MediWound, Kaken Pharma, Kerecis, Medline, Mallinckrodt Pharma

M2 Presswire, 2024-04-26

COPYRIGHT 2024 Normans Media Ltd.

Digital Resources/Online E-Resources

2
Cholangiocarcinoma Pipeline and Clinical Trials Assessment, 2024 Updates: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Merck KGaA, Eisai, Janssen Research Development, LLC
Material Type:
Newspaper Article
Add to My Research

Cholangiocarcinoma Pipeline and Clinical Trials Assessment, 2024 Updates: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Merck KGaA, Eisai, Janssen Research Development, LLC

M2 Presswire, 2024-02-21

COPYRIGHT 2024 Normans Media Ltd.

Digital Resources/Online E-Resources

3
Paroxysmal Nocturnal Hemoglobinuria Pipeline Analysis | Latest FDA, EMA, and PMDA Approvals | Alexion Pharma, Apellis Pharma, Hoffmann-La Roche, Novartis, Regeneron Pharma, RA Pharma
Material Type:
Newspaper Article
Add to My Research

Paroxysmal Nocturnal Hemoglobinuria Pipeline Analysis | Latest FDA, EMA, and PMDA Approvals | Alexion Pharma, Apellis Pharma, Hoffmann-La Roche, Novartis, Regeneron Pharma, RA Pharma

M2 Presswire, 2024-01-10

COPYRIGHT 2024 Normans Media Ltd.

Digital Resources/Online E-Resources

4
Degenerative Disc Disease Pipeline Review | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | Mesoblast, DiscGenics, Biosplice Therapeutics
Material Type:
Newspaper Article
Add to My Research

Degenerative Disc Disease Pipeline Review | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | Mesoblast, DiscGenics, Biosplice Therapeutics

M2 Presswire, 2023-12-19

COPYRIGHT 2023 Normans Media Ltd.

Digital Resources/Online E-Resources

5
Primary Sclerosing Cholangitis Pipeline Analysis, 2023 Updates | Latest FDA, EMA, and PMDA Approvals | Engitix, GRI Bio, Qing Bile Therapeutics, Sirnaomics, Cascade Pharma, Chemomab Therapeutics
Material Type:
Newspaper Article
Add to My Research

Primary Sclerosing Cholangitis Pipeline Analysis, 2023 Updates | Latest FDA, EMA, and PMDA Approvals | Engitix, GRI Bio, Qing Bile Therapeutics, Sirnaomics, Cascade Pharma, Chemomab Therapeutics

M2 Presswire, 2023-12-15

COPYRIGHT 2023 Normans Media Ltd.

Digital Resources/Online E-Resources

6
Overactive Bladder Clinical Trials (2023 Update): FDA Approvals, Therapies, Mechanisms of Action, Routes of Administration by DelveInsight | Astellas Pharma, Laborie, Hisamitsu Pharma, Medtronic
Material Type:
Newspaper Article
Add to My Research

Overactive Bladder Clinical Trials (2023 Update): FDA Approvals, Therapies, Mechanisms of Action, Routes of Administration by DelveInsight | Astellas Pharma, Laborie, Hisamitsu Pharma, Medtronic

M2 Presswire, 2023-12-13

COPYRIGHT 2023 Normans Media Ltd.

Digital Resources/Online E-Resources

7
Persistent Corneal Epithelial Defects Pipeline Drugs Analysis Report (2023 Updates): FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | RegeneRx
Material Type:
Newspaper Article
Add to My Research

Persistent Corneal Epithelial Defects Pipeline Drugs Analysis Report (2023 Updates): FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | RegeneRx

M2 Presswire, 2023-10-12

COPYRIGHT 2023 Normans Media Ltd.

Digital Resources/Online E-Resources

8
Rhabdomyosarcoma Clinical Trial Analysis Research 2023: Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries
Material Type:
Newspaper Article
Add to My Research

Rhabdomyosarcoma Clinical Trial Analysis Research 2023: Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries

M2 Presswire, 2023-07-06

COPYRIGHT 2023 Normans Media Ltd.

Digital Resources/Online E-Resources

9
Abbott Announces New Partnerships and Programs To Advance Its Diversity in Clinical Trials Initiative
Material Type:
Newspaper Article
Add to My Research

Abbott Announces New Partnerships and Programs To Advance Its Diversity in Clinical Trials Initiative

M2 Presswire, 2023-05-12

COPYRIGHT 2023 Normans Media Ltd.

Digital Resources/Online E-Resources

10
World Clinical Trials Racial Representation Data Study 2022: The Importance of Diversity in Clinical Trials - Analysis of Racial Representation Across Multiple Clinical Trial Sectors
Material Type:
Newspaper Article
Add to My Research

World Clinical Trials Racial Representation Data Study 2022: The Importance of Diversity in Clinical Trials - Analysis of Racial Representation Across Multiple Clinical Trial Sectors

M2 Presswire, 2022-11-07

COPYRIGHT 2022 Normans Media Ltd.

Digital Resources/Online E-Resources

11
Global Clinical Trials Connect 2022: Two Day Virtual Summit, September 21-22, 2022
Material Type:
Newspaper Article
Add to My Research

Global Clinical Trials Connect 2022: Two Day Virtual Summit, September 21-22, 2022

M2 Presswire, 2022-06-13

COPYRIGHT 2022 Normans Media Ltd.

Digital Resources/Online E-Resources

12
The Worldwide Clinical Trial Supplies Industry is Projected to Reach $4.2 Billion by 2027
Material Type:
Newspaper Article
Add to My Research

The Worldwide Clinical Trial Supplies Industry is Projected to Reach $4.2 Billion by 2027

M2 Presswire, 2022-06-09

COPYRIGHT 2022 Normans Media Ltd.

Digital Resources/Online E-Resources

13
Three ground-breaking clinical studies show the future of post-operative care and rapid discharge
Material Type:
Newspaper Article
Add to My Research

Three ground-breaking clinical studies show the future of post-operative care and rapid discharge

M2 Presswire, 2022-06-09

COPYRIGHT 2022 Normans Media Ltd.

Digital Resources/Online E-Resources

14
Three Day Accredited Beginners Clinical Trial Administrator (CTA) Course, July 4-6, 2022
Material Type:
Newspaper Article
Add to My Research

Three Day Accredited Beginners Clinical Trial Administrator (CTA) Course, July 4-6, 2022

M2 Presswire, 2022-05-09

COPYRIGHT 2022 Normans Media Ltd.

Digital Resources/Online E-Resources

15
Three Day Clinical Research Associate Skills Beginners F2F Course (October 17-19, 2022)
Material Type:
Newspaper Article
Add to My Research

Three Day Clinical Research Associate Skills Beginners F2F Course (October 17-19, 2022)

M2 Presswire, 2022-05-09

COPYRIGHT 2022 Normans Media Ltd.

Digital Resources/Online E-Resources

16
Three Day Accredited Clinical Trial Administrator Beginners Course, October 10-12, 2022
Material Type:
Newspaper Article
Add to My Research

Three Day Accredited Clinical Trial Administrator Beginners Course, October 10-12, 2022

M2 Presswire, 2022-05-09

COPYRIGHT 2022 Normans Media Ltd.

Digital Resources/Online E-Resources

17
Real World Evidence Clinical Trials Research Report 2021: Data by Year, Phase, Status, Therapy Area, Indication, Geography, Sponsor Type, and Reasons For Discontinuation
Material Type:
Newspaper Article
Add to My Research

Real World Evidence Clinical Trials Research Report 2021: Data by Year, Phase, Status, Therapy Area, Indication, Geography, Sponsor Type, and Reasons For Discontinuation

M2 Presswire, 2022-04-26

COPYRIGHT 2022 Normans Media Ltd.

Digital Resources/Online E-Resources

18
Global Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Clinical Trials Research Review 2022
Material Type:
Newspaper Article
Add to My Research

Global Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Clinical Trials Research Review 2022

M2 Presswire, 2022-04-13

COPYRIGHT 2022 Normans Media Ltd.

Digital Resources/Online E-Resources

19
Global Keratoconjunctivitis Sicca (Dry Eye) Clinical Trials Research Report 2022
Material Type:
Newspaper Article
Add to My Research

Global Keratoconjunctivitis Sicca (Dry Eye) Clinical Trials Research Report 2022

M2 Presswire, 2022-04-06

COPYRIGHT 2022 Normans Media Ltd.

Digital Resources/Online E-Resources

20
Global Contract Research Organization (CRO) Industry Assessment 2021-2028 - Set to Cross $88.8 Billion by 2028 with Clinical Research Services Expected to Register the Highest CAGR
Material Type:
Newspaper Article
Add to My Research

Global Contract Research Organization (CRO) Industry Assessment 2021-2028 - Set to Cross $88.8 Billion by 2028 with Clinical Research Services Expected to Register the Highest CAGR

M2 Presswire, 2021-12-08

COPYRIGHT 2021 Normans Media Ltd.

Digital Resources/Online E-Resources

Results 1 - 20 of 1,037  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2011  (21)
  2. 2011 To 2012  (59)
  3. 2013 To 2017  (89)
  4. 2018 To 2021  (209)
  5. After 2021  (660)
  6. More options open sub menu

Searching Remote Databases, Please Wait